Hester Biosciences: Independent Director Ameetkumar Desai Completes Board Tenure
Hester Biosciences Ltd 路 Others (Uncategorized) 路 27 Oct 2026, 4:16 pm
Hester Biosciences: Independent Director Ameetkumar Desai Completes Board Tenure Hester Biosciences Limited announced that Independent Director Mr. Ameetkumar Desai (DIN: 00007116) has decided not to seek reappointment for a second consecutive term. Consequently, Mr. Desai ceased to be an Independent Director of the company effective from the close of business hours on 27th Oct'26 upon the completion of his first term, in compliance with Regulation 30 of the SEBI Listing Regulations.
Original exchange filing (PDF)
More announcements from Hester Biosciences Ltd
- 20261105 Transcript of Earnings Conference Call for Q2 & H1 FY27 Financial Results 路 07 Nov 2026
- Audio recording of the Earnings Conference Call for Q2 FY 27 路 05 Nov 2026
- Hester Biosciences Limited has informed the Exchange about Board have approved an Unsecured loan of an aggregate amount of USD 1 million to Hester Biosciences Africa Limited( Hester Africa ), foreign wholly-owned subsidiary in Tanzania, in one or more tranches. 路 05 Nov 2026
- Disclosure under regulation 30 of Listing Regulations - Board of Directors approved an unsecured loan to Hester Biosciences Africa Limited, Foreign wholly-owned subsidiary of the Company. 路 05 Nov 2026
- Hester Biosciences Limited has informed the Exchange regarding a press release dated November 05, 2026, titled "20261105 Q2 & H1 FY27 Press Release". 路 05 Nov 2026
- 20261105 Q2 & H1 FY27 Press Release 路 05 Nov 2026
- Hester Biosciences Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 05 Nov 2026
- Outcome of Board Meeting held on 5 November 2026 and Financial Results for the Q2 & H1 FY 2026-27 路 05 Nov 2026
